Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) models
dc.contributor.author | Singulani, Junya De Lacorte [UNESP] | |
dc.contributor.author | Scorzoni, Liliana [UNESP] | |
dc.contributor.author | Gomes, Paulo César [UNESP] | |
dc.contributor.author | Nazaré, Ana Carolina [UNESP] | |
dc.contributor.author | Polaquini, Carlos Roberto [UNESP] | |
dc.contributor.author | Regasini, Luis Octávio [UNESP] | |
dc.contributor.author | Fusco-Almeida, Ana Marisa [UNESP] | |
dc.contributor.author | Mendes-Giannini, Maria José Soares [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2018-12-11T17:16:09Z | |
dc.date.available | 2018-12-11T17:16:09Z | |
dc.date.issued | 2017-10-01 | |
dc.description.abstract | Aim: Gallic acid and its ester derivatives have shown antifungal activity in vitro. This study was performed to investigate their activity against Candida albicans and their toxicity in the animal models Caenorhabditis elegans and zebrafish embryos. Results: The compounds protected worms from C. albicans infection. The dodecyl gallate was the most effective. In zebrafish embryo, gallic acid and dodecyl gallate were the least toxic. Conclusion: Gallic acid and its ester derivatives have potential for in vivo use against C. albicans infection. The antifungal effects and toxicity of gallate esters in these alternative animal models were dependent on carbon chain length. | en |
dc.description.affiliation | Department of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University-UNESP | |
dc.description.affiliation | Department of Chemistry and Environmental Sciences Institute of Biosciences Humanities and Exact Sciences São Paulo State University-UNESP | |
dc.description.affiliationUnesp | Department of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University-UNESP | |
dc.description.affiliationUnesp | Department of Chemistry and Environmental Sciences Institute of Biosciences Humanities and Exact Sciences São Paulo State University-UNESP | |
dc.format.extent | 1863-1872 | |
dc.identifier | http://dx.doi.org/10.4155/fmc-2017-0096 | |
dc.identifier.citation | Future Medicinal Chemistry, v. 9, n. 16, p. 1863-1872, 2017. | |
dc.identifier.doi | 10.4155/fmc-2017-0096 | |
dc.identifier.issn | 1756-8927 | |
dc.identifier.issn | 1756-8919 | |
dc.identifier.lattes | 3637285622123132 | |
dc.identifier.lattes | 0992736452764550 | |
dc.identifier.orcid | 0000-0003-2440-8097 | |
dc.identifier.scopus | 2-s2.0-85034666874 | |
dc.identifier.uri | http://hdl.handle.net/11449/175523 | |
dc.language.iso | eng | |
dc.relation.ispartof | Future Medicinal Chemistry | |
dc.relation.ispartofsjr | 1,111 | |
dc.relation.ispartofsjr | 1,111 | |
dc.rights.accessRights | Acesso restrito | |
dc.source | Scopus | |
dc.subject | alternative animal models | |
dc.subject | antifungal development | |
dc.subject | gallates | |
dc.subject | gallic acid | |
dc.subject | infection | |
dc.title | Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) models | en |
dc.type | Artigo | |
unesp.author.lattes | 3637285622123132[3] | |
unesp.author.lattes | 0992736452764550 | |
unesp.author.lattes | 3716273524139678[7] | |
unesp.author.orcid | 0000-0003-2440-8097[3] | |
unesp.author.orcid | 0000-0002-2115-8988[7] | |
unesp.department | Análises Clínicas - FCF | pt |